Keywords: watson, gel, reduces, urinary, incontinence, new, phase
Watson gel reduces urinary incontinence
Article | 23 March 2009
New Phase III data, published in The Journal of Urology shows USA-based Watson Pharmaceuticals Gelnique (oxybutynin chloride) Gel 10% is effective ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
